PD-1 drugs for Colorectal Cancer
4 tracked PD-1 drugs in the Colorectal Cancer race. The class explanation lives on the PD-1 page; the full indication pipeline across every mechanism is on the Colorectal Cancer page.
4 approved / phase 4
Head-to-head evidence: Nivolumab vs Opdivo Qvantig · Nivolumab vs Pembrolizumab · Nivolumab vs Pembrolizumab berahyaluronidase alfa · Opdivo Qvantig vs Pembrolizumab · Pembrolizumab vs Pembrolizumab berahyaluronidase alfa